United States

Back to map

Showing 271-280 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 31-August-2025 $110.840,00
Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes University of Washington Ian De Boer Improving Lives 01-September-2023 to 31-August-2026 $2.107.411,00
Effectiveness and safety of sotagliflozin in slowing kidney function decline in persons with type 1 diabetes and moderate to severe diabetic kidney disease: The SUGARNSALT Trial Joslin Diabetes Center Inc. Alessandro Doria Improving Lives 01-January-2024 to 31-December-2028 $8.913.450,00
Preclinical development of a combinatorial therapy with a humanized antibody to serpinB13 in type 1 diabetes Regents of the University of Minnesota Jan Czyzyk Cures 01-June-2022 to 31-May-2025 $765.000,00
Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes Rector & Visitors of the University of Virginia William Horton Improving Lives 01-December-2022 to 30-November-2025 $858.072,00
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D Neurodon LLC Russell Dahl Cures 01-June-2022 to 31-October-2025 $920.000,00
Developing fusion therapeutics to selectively target beta cell surface receptors for treating T1D UT Southwestern Wen-hong Li Cures 01-July-2022 to 30-June-2025 $900.000,00
Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial University of California, San Diego Charles Ginsberg Improving Lives 01-November-2022 to 31-October-2026 $1.356.726,45
Harnessing zinc-tropic agents for targeted delivery of therapeutics to islet beta cells for preventing or treating T1D UT Southwestern Wen-hong Li Cures 01-August-2022 to 31-October-2025 $900.000,00
Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2022 to 31-May-2026 $600.000,00